TY - JOUR
AU - Dubey, Ankit Kumar
AU - Chaudhry, Suman Kumar
AU - Singh, Harikesh Bahadur
AU - Gupta, Vijai Kumar
AU - Kaushik, Ajeet
PY - 2022
DA - March
TI - Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections
JO - Biotechnology Reports
VL - 33
DO - https://doi.org/10.1016/j.btre.2022.e00712
AB - Optimized therapeutic bio-compounds supported by bio-acceptable nanosystems (i.e., precise nanomedicine) have ability to promote health via maintaining body structure, organ function, and controlling chronic and acute effects. Therefore, nano-nutraceuticals (designed to neutralize virus, inhibit virus bindings with receptors, and support immunity) utilization can manage COVID-19 pre/post-infection effects. To explore these approaches well, our mini-review explores optimized bio-active compounds, their ability to influence SARS-CoV-2 infection, improvement in performance supported by precise nanomedicine approach, and challenges along with prospects. Such optimized pharmacologically relevant therapeutic cargo not only affect SARS-CoV-2 but will support other organs which show functional alternation due to SARS-CoV-2 for example, neurological functions. Hence, coupling the nutraceuticals with the nano-pharmacology perspective of higher efficacy via targeted delivery action can pave a novel way for health experts to plan future research needed to manage post COVID-19 infection effect where a longer efficacy with no side-effects is a key requirement.
PB - Elsevier
UR - https://pure.sruc.ac.uk/en/publications/perspectives-on-nano-nutraceuticals-to-manage-pre-and-post-covid-
KW - Coronavirus (COVID-19)
ER